SEBULSKY ALAN purchased 140.0% of their position (17.50K shares) of PARABILIS MEDICINES, INC. on the open market
Open‑market purchase worth $473.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 6/16/2026ACC: 0001193125-26-273013
+17.50K
Net shares
Net buyer
$473.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
17.50K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+8.44K
Price / share
$27.67
Trade value
$233.39K
% of position
67.5%
6/12/2026
12.50K→20.93K
Common Stock
Indirect
Shares
+5K
Price / share
$26.00
Trade value
$129.99K
% of position
23.9%
6/15/2026
20.93K→25.93K
Common Stock
Indirect
Shares
+4.07K
Price / share
$27.10
Trade value
$110.15K
% of position
15.7%
6/15/2026
25.93K→30K
Total
Net shares
+17.50K
Net value
$473.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/12/2026 | P · Purchase | +8.44K | $27.67 | $233.39K | 67.5% | 12.50K | 20.93K |
| Common Stock Indirect | 6/15/2026 | P · Purchase | +5K | $26.00 | $129.99K | 23.9% | 20.93K | 25.93K |
| Common Stock Indirect | 6/15/2026 | P · Purchase | +4.07K | $27.10 | $110.15K | 15.7% | 25.93K | 30K |
| Total | +17.50K | $473.53K | ||||||
Derivative Transactions0
No derivative transactions reported